nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—ALB—multiple sclerosis	0.42	1	CbGaD
Repaglinide—ALB—Prednisone—multiple sclerosis	0.0594	0.162	CbGbCtD
Repaglinide—SLCO1B1—Methotrexate—multiple sclerosis	0.0545	0.149	CbGbCtD
Repaglinide—CYP3A4—Fingolimod—multiple sclerosis	0.0477	0.13	CbGbCtD
Repaglinide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0308	0.0839	CbGbCtD
Repaglinide—ALB—Methotrexate—multiple sclerosis	0.0298	0.0814	CbGbCtD
Repaglinide—CYP2C8—Dexamethasone—multiple sclerosis	0.0287	0.0782	CbGbCtD
Repaglinide—CYP3A4—Triamcinolone—multiple sclerosis	0.0233	0.0636	CbGbCtD
Repaglinide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0224	0.0612	CbGbCtD
Repaglinide—CYP3A4—Betamethasone—multiple sclerosis	0.02	0.0545	CbGbCtD
Repaglinide—CYP3A4—Prednisolone—multiple sclerosis	0.0197	0.0538	CbGbCtD
Repaglinide—CYP3A4—Prednisone—multiple sclerosis	0.0186	0.0508	CbGbCtD
Repaglinide—CYP3A4—Dexamethasone—multiple sclerosis	0.0116	0.0317	CbGbCtD
Repaglinide—PPARG—leg—multiple sclerosis	0.0014	0.269	CbGeAlD
Repaglinide—ABCC8—Neuronal System—KCNA3—multiple sclerosis	0.000636	0.0143	CbGpPWpGaD
Repaglinide—SLCO1B1—Transport of organic anions—ALB—multiple sclerosis	0.00063	0.0142	CbGpPWpGaD
Repaglinide—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.000624	0.00382	CcSEcCtD
Repaglinide—Vasculitis—Methotrexate—multiple sclerosis	0.00062	0.0038	CcSEcCtD
Repaglinide—KCNJ11—Neuronal System—KCNA3—multiple sclerosis	0.000616	0.0139	CbGpPWpGaD
Repaglinide—Pancreatitis—Prednisolone—multiple sclerosis	0.000613	0.00375	CcSEcCtD
Repaglinide—Rhinitis—Mitoxantrone—multiple sclerosis	0.000612	0.00375	CcSEcCtD
Repaglinide—Hepatitis—Mitoxantrone—multiple sclerosis	0.00061	0.00374	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000601	0.00368	CcSEcCtD
Repaglinide—Paraesthesia—Cladribine—multiple sclerosis	0.000592	0.00363	CcSEcCtD
Repaglinide—Leukopenia—Azathioprine—multiple sclerosis	0.000588	0.0036	CcSEcCtD
Repaglinide—Cardiac failure congestive—Prednisone—multiple sclerosis	0.00058	0.00355	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00057	0.00349	CcSEcCtD
Repaglinide—Constipation—Cladribine—multiple sclerosis	0.000564	0.00345	CcSEcCtD
Repaglinide—Pancreatitis—Triamcinolone—multiple sclerosis	0.000564	0.00345	CcSEcCtD
Repaglinide—Pancreatitis—Methylprednisolone—multiple sclerosis	0.000563	0.00345	CcSEcCtD
Repaglinide—Arthralgia—Azathioprine—multiple sclerosis	0.00056	0.00343	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000556	0.0034	CcSEcCtD
Repaglinide—Bronchitis—Triamcinolone—multiple sclerosis	0.000553	0.00339	CcSEcCtD
Repaglinide—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.00055	0.00337	CcSEcCtD
Repaglinide—Myocardial infarction—Prednisolone—multiple sclerosis	0.000547	0.00335	CcSEcCtD
Repaglinide—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000545	0.00334	CcSEcCtD
Repaglinide—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000539	0.0033	CcSEcCtD
Repaglinide—Alopecia—Mitoxantrone—multiple sclerosis	0.000539	0.0033	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000535	0.0121	CbGpPWpGaD
Repaglinide—Erythema—Mitoxantrone—multiple sclerosis	0.000531	0.00325	CcSEcCtD
Repaglinide—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000525	0.00322	CcSEcCtD
Repaglinide—Urticaria—Cladribine—multiple sclerosis	0.000524	0.00321	CcSEcCtD
Repaglinide—Abdominal pain—Cladribine—multiple sclerosis	0.000522	0.00319	CcSEcCtD
Repaglinide—Skin disorder—Azathioprine—multiple sclerosis	0.000521	0.00319	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000517	0.0117	CbGpPWpGaD
Repaglinide—Back pain—Mitoxantrone—multiple sclerosis	0.000514	0.00315	CcSEcCtD
Repaglinide—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000506	0.0031	CcSEcCtD
Repaglinide—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000505	0.00309	CcSEcCtD
Repaglinide—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000503	0.00308	CcSEcCtD
Repaglinide—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000502	0.00307	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000489	0.00299	CcSEcCtD
Repaglinide—Hypersensitivity—Cladribine—multiple sclerosis	0.000486	0.00298	CcSEcCtD
Repaglinide—Visual impairment—Prednisolone—multiple sclerosis	0.000483	0.00295	CcSEcCtD
Repaglinide—Leukopenia—Mitoxantrone—multiple sclerosis	0.000476	0.00291	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	0.000475	0.0107	CbGpPWpGaD
Repaglinide—PPARG—Nuclear Receptors—VDR—multiple sclerosis	0.000473	0.0107	CbGpPWpGaD
Repaglinide—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000471	0.00288	CcSEcCtD
Repaglinide—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000471	0.00288	CcSEcCtD
Repaglinide—Pruritus—Cladribine—multiple sclerosis	0.000467	0.00286	CcSEcCtD
Repaglinide—SLCO1B1—Recycling of bile acids and salts—ALB—multiple sclerosis	0.000467	0.0105	CbGpPWpGaD
Repaglinide—Visual disturbance—Methotrexate—multiple sclerosis	0.000464	0.00284	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000463	0.00283	CcSEcCtD
Repaglinide—Rhinitis—Triamcinolone—multiple sclerosis	0.000462	0.00283	CcSEcCtD
Repaglinide—Rhinitis—Methylprednisolone—multiple sclerosis	0.000461	0.00282	CcSEcCtD
Repaglinide—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000459	0.00281	CcSEcCtD
Repaglinide—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000459	0.00281	CcSEcCtD
Repaglinide—Hypertension—Mitoxantrone—multiple sclerosis	0.000459	0.00281	CcSEcCtD
Repaglinide—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000456	0.00279	CcSEcCtD
Repaglinide—Myocardial infarction—Betamethasone—multiple sclerosis	0.000456	0.00279	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000454	0.00278	CcSEcCtD
Repaglinide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000454	0.0102	CbGpPWpGaD
Repaglinide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000454	0.0102	CbGpPWpGaD
Repaglinide—Arthralgia—Mitoxantrone—multiple sclerosis	0.000452	0.00277	CcSEcCtD
Repaglinide—Chest pain—Mitoxantrone—multiple sclerosis	0.000452	0.00277	CcSEcCtD
Repaglinide—Diarrhoea—Cladribine—multiple sclerosis	0.000451	0.00276	CcSEcCtD
Repaglinide—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000448	0.0101	CbGpPWpGaD
Repaglinide—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000448	0.0101	CbGpPWpGaD
Repaglinide—Arrhythmia—Prednisolone—multiple sclerosis	0.000447	0.00274	CcSEcCtD
Repaglinide—Pancreatitis—Prednisone—multiple sclerosis	0.000446	0.00273	CcSEcCtD
Repaglinide—Visual impairment—Methylprednisolone—multiple sclerosis	0.000443	0.00271	CcSEcCtD
Repaglinide—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000439	0.00269	CcSEcCtD
Repaglinide—Erythema—Prednisolone—multiple sclerosis	0.000436	0.00267	CcSEcCtD
Repaglinide—Oedema—Mitoxantrone—multiple sclerosis	0.000434	0.00265	CcSEcCtD
Repaglinide—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000434	0.00265	CcSEcCtD
Repaglinide—Eye disorder—Methylprednisolone—multiple sclerosis	0.000429	0.00263	CcSEcCtD
Repaglinide—ABCC8—brainstem—multiple sclerosis	0.000427	0.0822	CbGeAlD
Repaglinide—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000426	0.00261	CcSEcCtD
Repaglinide—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000425	0.0026	CcSEcCtD
Repaglinide—Abdominal pain—Azathioprine—multiple sclerosis	0.000424	0.0026	CcSEcCtD
Repaglinide—Skin disorder—Mitoxantrone—multiple sclerosis	0.000421	0.00258	CcSEcCtD
Repaglinide—Vomiting—Cladribine—multiple sclerosis	0.000419	0.00257	CcSEcCtD
Repaglinide—Rash—Cladribine—multiple sclerosis	0.000416	0.00255	CcSEcCtD
Repaglinide—Dermatitis—Cladribine—multiple sclerosis	0.000416	0.00254	CcSEcCtD
Repaglinide—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000415	0.00254	CcSEcCtD
Repaglinide—Headache—Cladribine—multiple sclerosis	0.000413	0.00253	CcSEcCtD
Repaglinide—Arrhythmia—Triamcinolone—multiple sclerosis	0.000411	0.00252	CcSEcCtD
Repaglinide—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00041	0.00251	CcSEcCtD
Repaglinide—Hyperglycaemia—Prednisone—multiple sclerosis	0.00041	0.00251	CcSEcCtD
Repaglinide—Visual impairment—Dexamethasone—multiple sclerosis	0.000403	0.00246	CcSEcCtD
Repaglinide—Visual impairment—Betamethasone—multiple sclerosis	0.000403	0.00246	CcSEcCtD
Repaglinide—Erythema—Triamcinolone—multiple sclerosis	0.000401	0.00245	CcSEcCtD
Repaglinide—Erythema—Methylprednisolone—multiple sclerosis	0.0004	0.00245	CcSEcCtD
Repaglinide—Malnutrition—Methylprednisolone—multiple sclerosis	0.0004	0.00245	CcSEcCtD
Repaglinide—Acute coronary syndrome—Prednisone—multiple sclerosis	0.0004	0.00245	CcSEcCtD
Repaglinide—Myocardial infarction—Prednisone—multiple sclerosis	0.000397	0.00243	CcSEcCtD
Repaglinide—Hypersensitivity—Azathioprine—multiple sclerosis	0.000395	0.00242	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000395	0.00242	CcSEcCtD
Repaglinide—Nausea—Cladribine—multiple sclerosis	0.000392	0.0024	CcSEcCtD
Repaglinide—Eye disorder—Betamethasone—multiple sclerosis	0.00039	0.00239	CcSEcCtD
Repaglinide—Eye disorder—Dexamethasone—multiple sclerosis	0.00039	0.00239	CcSEcCtD
Repaglinide—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000389	0.00238	CcSEcCtD
Repaglinide—Back pain—Triamcinolone—multiple sclerosis	0.000388	0.00237	CcSEcCtD
Repaglinide—KCNJ11—Type II diabetes mellitus—MAPK1—multiple sclerosis	0.000386	0.00868	CbGpPWpGaD
Repaglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000384	0.00865	CbGpPWpGaD
Repaglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000384	0.00865	CbGpPWpGaD
Repaglinide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000382	0.00234	CcSEcCtD
Repaglinide—Hypertension—Prednisolone—multiple sclerosis	0.000376	0.0023	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000374	0.00842	CbGpPWpGaD
Repaglinide—Arrhythmia—Dexamethasone—multiple sclerosis	0.000373	0.00228	CcSEcCtD
Repaglinide—Arrhythmia—Betamethasone—multiple sclerosis	0.000373	0.00228	CcSEcCtD
Repaglinide—Pancreatitis—Methotrexate—multiple sclerosis	0.000372	0.00228	CcSEcCtD
Repaglinide—Constipation—Mitoxantrone—multiple sclerosis	0.000371	0.00227	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	0.00037	0.00832	CbGpPWpGaD
Repaglinide—Alopecia—Dexamethasone—multiple sclerosis	0.000369	0.00226	CcSEcCtD
Repaglinide—Alopecia—Betamethasone—multiple sclerosis	0.000369	0.00226	CcSEcCtD
Repaglinide—PPARG—Signaling events mediated by HDAC Class I—TNFRSF1A—multiple sclerosis	0.000368	0.0083	CbGpPWpGaD
Repaglinide—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000368	0.00829	CbGpPWpGaD
Repaglinide—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000368	0.00829	CbGpPWpGaD
Repaglinide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.000368	0.00829	CbGpPWpGaD
Repaglinide—KCNJ11—Type II diabetes mellitus—TNF—multiple sclerosis	0.000367	0.00827	CbGpPWpGaD
Repaglinide—Diarrhoea—Azathioprine—multiple sclerosis	0.000367	0.00225	CcSEcCtD
Repaglinide—Erythema—Betamethasone—multiple sclerosis	0.000364	0.00223	CcSEcCtD
Repaglinide—Erythema—Dexamethasone—multiple sclerosis	0.000364	0.00223	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	0.00036	0.0081	CbGpPWpGaD
Repaglinide—ALB—HDL-mediated lipid transport—APOE—multiple sclerosis	0.000358	0.00807	CbGpPWpGaD
Repaglinide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.000357	0.00804	CbGpPWpGaD
Repaglinide—Oedema—Prednisolone—multiple sclerosis	0.000356	0.00218	CcSEcCtD
Repaglinide—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000356	0.00218	CcSEcCtD
Repaglinide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000355	0.00217	CcSEcCtD
Repaglinide—Hypertension—Triamcinolone—multiple sclerosis	0.000346	0.00212	CcSEcCtD
Repaglinide—Hypertension—Methylprednisolone—multiple sclerosis	0.000345	0.00211	CcSEcCtD
Repaglinide—Urticaria—Mitoxantrone—multiple sclerosis	0.000344	0.00211	CcSEcCtD
Repaglinide—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000343	0.0021	CcSEcCtD
Repaglinide—Vomiting—Azathioprine—multiple sclerosis	0.000341	0.00209	CcSEcCtD
Repaglinide—Arthralgia—Methylprednisolone—multiple sclerosis	0.000341	0.00208	CcSEcCtD
Repaglinide—Eye disorder—Prednisone—multiple sclerosis	0.00034	0.00208	CcSEcCtD
Repaglinide—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.00034	0.00766	CbGpPWpGaD
Repaglinide—Rash—Azathioprine—multiple sclerosis	0.000338	0.00207	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000338	0.00207	CcSEcCtD
Repaglinide—Dermatitis—Azathioprine—multiple sclerosis	0.000338	0.00207	CcSEcCtD
Repaglinide—Headache—Azathioprine—multiple sclerosis	0.000336	0.00206	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000336	0.00206	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	0.000329	0.00742	CbGpPWpGaD
Repaglinide—Immune system disorder—Prednisone—multiple sclerosis	0.000329	0.00201	CcSEcCtD
Repaglinide—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000327	0.002	CcSEcCtD
Repaglinide—Oedema—Triamcinolone—multiple sclerosis	0.000327	0.002	CcSEcCtD
Repaglinide—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000326	0.002	CcSEcCtD
Repaglinide—Arrhythmia—Prednisone—multiple sclerosis	0.000325	0.00199	CcSEcCtD
Repaglinide—PPARG—Developmental Biology—CD24—multiple sclerosis	0.000324	0.00729	CbGpPWpGaD
Repaglinide—Alopecia—Prednisone—multiple sclerosis	0.000322	0.00197	CcSEcCtD
Repaglinide—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00032	0.00196	CcSEcCtD
Repaglinide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000319	0.00196	CcSEcCtD
Repaglinide—Paraesthesia—Prednisolone—multiple sclerosis	0.000319	0.00196	CcSEcCtD
Repaglinide—Nausea—Azathioprine—multiple sclerosis	0.000319	0.00195	CcSEcCtD
Repaglinide—Skin disorder—Methylprednisolone—multiple sclerosis	0.000317	0.00194	CcSEcCtD
Repaglinide—Erythema—Prednisone—multiple sclerosis	0.000317	0.00194	CcSEcCtD
Repaglinide—Malnutrition—Prednisone—multiple sclerosis	0.000317	0.00194	CcSEcCtD
Repaglinide—Hypertension—Dexamethasone—multiple sclerosis	0.000314	0.00192	CcSEcCtD
Repaglinide—Hypertension—Betamethasone—multiple sclerosis	0.000314	0.00192	CcSEcCtD
Repaglinide—PPARG—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000306	0.0069	CbGpPWpGaD
Repaglinide—Hepatitis—Methotrexate—multiple sclerosis	0.000304	0.00186	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000298	0.00182	CcSEcCtD
Repaglinide—ABCC8—medulla oblongata—multiple sclerosis	0.000298	0.0573	CbGeAlD
Repaglinide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000297	0.00182	CcSEcCtD
Repaglinide—Oedema—Betamethasone—multiple sclerosis	0.000297	0.00182	CcSEcCtD
Repaglinide—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000297	0.00182	CcSEcCtD
Repaglinide—Oedema—Dexamethasone—multiple sclerosis	0.000297	0.00182	CcSEcCtD
Repaglinide—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000297	0.00182	CcSEcCtD
Repaglinide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000297	0.00182	CcSEcCtD
Repaglinide—Paraesthesia—Triamcinolone—multiple sclerosis	0.000294	0.0018	CcSEcCtD
Repaglinide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000293	0.00179	CcSEcCtD
Repaglinide—Visual impairment—Methotrexate—multiple sclerosis	0.000293	0.00179	CcSEcCtD
Repaglinide—ALB—Platelet degranulation—PLEK—multiple sclerosis	0.000292	0.00659	CbGpPWpGaD
Repaglinide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000291	0.00178	CcSEcCtD
Repaglinide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000291	0.00178	CcSEcCtD
Repaglinide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000288	0.00176	CcSEcCtD
Repaglinide—Erythema multiforme—Methotrexate—multiple sclerosis	0.000288	0.00176	CcSEcCtD
Repaglinide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000287	0.00176	CcSEcCtD
Repaglinide—Eye disorder—Methotrexate—multiple sclerosis	0.000284	0.00174	CcSEcCtD
Repaglinide—Urticaria—Prednisolone—multiple sclerosis	0.000283	0.00173	CcSEcCtD
Repaglinide—Cardiac disorder—Methotrexate—multiple sclerosis	0.000282	0.00173	CcSEcCtD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000279	0.00627	CbGpPWpGaD
Repaglinide—Vomiting—Mitoxantrone—multiple sclerosis	0.000276	0.00169	CcSEcCtD
Repaglinide—Immune system disorder—Methotrexate—multiple sclerosis	0.000275	0.00168	CcSEcCtD
Repaglinide—Hypertension—Prednisone—multiple sclerosis	0.000273	0.00167	CcSEcCtD
Repaglinide—Rash—Mitoxantrone—multiple sclerosis	0.000273	0.00167	CcSEcCtD
Repaglinide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000273	0.00167	CcSEcCtD
Repaglinide—ABCC8—midbrain—multiple sclerosis	0.000272	0.0524	CbGeAlD
Repaglinide—Headache—Mitoxantrone—multiple sclerosis	0.000272	0.00166	CcSEcCtD
Repaglinide—PPARG—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	0.000271	0.00611	CbGpPWpGaD
Repaglinide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00027	0.00166	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00027	0.00166	CcSEcCtD
Repaglinide—Arthralgia—Prednisone—multiple sclerosis	0.00027	0.00165	CcSEcCtD
Repaglinide—Alopecia—Methotrexate—multiple sclerosis	0.000269	0.00164	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000268	0.00164	CcSEcCtD
Repaglinide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000267	0.00163	CcSEcCtD
Repaglinide—Paraesthesia—Betamethasone—multiple sclerosis	0.000267	0.00163	CcSEcCtD
Repaglinide—Paraesthesia—Dexamethasone—multiple sclerosis	0.000267	0.00163	CcSEcCtD
Repaglinide—ABCC8—spinal cord—multiple sclerosis	0.000265	0.0511	CbGeAlD
Repaglinide—Malnutrition—Methotrexate—multiple sclerosis	0.000265	0.00162	CcSEcCtD
Repaglinide—Erythema—Methotrexate—multiple sclerosis	0.000265	0.00162	CcSEcCtD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000263	0.00592	CbGpPWpGaD
Repaglinide—Hypersensitivity—Prednisolone—multiple sclerosis	0.000262	0.0016	CcSEcCtD
Repaglinide—Dyspepsia—Dexamethasone—multiple sclerosis	0.000261	0.0016	CcSEcCtD
Repaglinide—Dyspepsia—Betamethasone—multiple sclerosis	0.000261	0.0016	CcSEcCtD
Repaglinide—Urticaria—Triamcinolone—multiple sclerosis	0.00026	0.00159	CcSEcCtD
Repaglinide—Urticaria—Methylprednisolone—multiple sclerosis	0.000259	0.00159	CcSEcCtD
Repaglinide—Oedema—Prednisone—multiple sclerosis	0.000259	0.00158	CcSEcCtD
Repaglinide—Anaphylactic shock—Prednisone—multiple sclerosis	0.000259	0.00158	CcSEcCtD
Repaglinide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000258	0.00158	CcSEcCtD
Repaglinide—Nausea—Mitoxantrone—multiple sclerosis	0.000258	0.00158	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000256	0.00157	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000256	0.00157	CcSEcCtD
Repaglinide—Back pain—Methotrexate—multiple sclerosis	0.000256	0.00157	CcSEcCtD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.000254	0.00573	CbGpPWpGaD
Repaglinide—Skin disorder—Prednisone—multiple sclerosis	0.000251	0.00154	CcSEcCtD
Repaglinide—SLCO1B1—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000244	0.00549	CbGpPWpGaD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000244	0.00549	CbGpPWpGaD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000244	0.00549	CbGpPWpGaD
Repaglinide—KCNJ11—nervous system—multiple sclerosis	0.000243	0.0467	CbGeAlD
Repaglinide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000243	0.00149	CcSEcCtD
Repaglinide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000243	0.00149	CcSEcCtD
Repaglinide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000241	0.00148	CcSEcCtD
Repaglinide—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000241	0.00542	CbGpPWpGaD
Repaglinide—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000241	0.00542	CbGpPWpGaD
Repaglinide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000241	0.00147	CcSEcCtD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.000237	0.00535	CbGpPWpGaD
Repaglinide—Leukopenia—Methotrexate—multiple sclerosis	0.000237	0.00145	CcSEcCtD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000237	0.00534	CbGpPWpGaD
Repaglinide—Urticaria—Betamethasone—multiple sclerosis	0.000236	0.00144	CcSEcCtD
Repaglinide—Urticaria—Dexamethasone—multiple sclerosis	0.000236	0.00144	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000236	0.00144	CcSEcCtD
Repaglinide—Abdominal pain—Betamethasone—multiple sclerosis	0.000235	0.00144	CcSEcCtD
Repaglinide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000235	0.00144	CcSEcCtD
Repaglinide—KCNJ11—central nervous system—multiple sclerosis	0.000234	0.045	CbGeAlD
Repaglinide—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000234	0.00526	CbGpPWpGaD
Repaglinide—Paraesthesia—Prednisone—multiple sclerosis	0.000232	0.00142	CcSEcCtD
Repaglinide—Pruritus—Triamcinolone—multiple sclerosis	0.000231	0.00142	CcSEcCtD
Repaglinide—Pruritus—Methylprednisolone—multiple sclerosis	0.000231	0.00141	CcSEcCtD
Repaglinide—KCNJ11—cerebellum—multiple sclerosis	0.000228	0.044	CbGeAlD
Repaglinide—Dyspepsia—Prednisone—multiple sclerosis	0.000228	0.00139	CcSEcCtD
Repaglinide—Chest pain—Methotrexate—multiple sclerosis	0.000225	0.00138	CcSEcCtD
Repaglinide—Arthralgia—Methotrexate—multiple sclerosis	0.000225	0.00138	CcSEcCtD
Repaglinide—Rash—Prednisolone—multiple sclerosis	0.000224	0.00137	CcSEcCtD
Repaglinide—Dermatitis—Prednisolone—multiple sclerosis	0.000224	0.00137	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000224	0.00137	CcSEcCtD
Repaglinide—ABCC8—nervous system—multiple sclerosis	0.000224	0.043	CbGeAlD
Repaglinide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000223	0.00137	CcSEcCtD
Repaglinide—Headache—Prednisolone—multiple sclerosis	0.000223	0.00136	CcSEcCtD
Repaglinide—Constipation—Prednisone—multiple sclerosis	0.000221	0.00135	CcSEcCtD
Repaglinide—PPARG—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	0.000219	0.00493	CbGpPWpGaD
Repaglinide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000219	0.00493	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.000217	0.0049	CbGpPWpGaD
Repaglinide—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000216	0.00132	CcSEcCtD
Repaglinide—ABCC8—central nervous system—multiple sclerosis	0.000215	0.0414	CbGeAlD
Repaglinide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000212	0.00129	CcSEcCtD
Repaglinide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000211	0.00129	CcSEcCtD
Repaglinide—Nausea—Prednisolone—multiple sclerosis	0.000211	0.00129	CcSEcCtD
Repaglinide—ABCC8—cerebellum—multiple sclerosis	0.00021	0.0405	CbGeAlD
Repaglinide—Pruritus—Dexamethasone—multiple sclerosis	0.00021	0.00129	CcSEcCtD
Repaglinide—Pruritus—Betamethasone—multiple sclerosis	0.00021	0.00129	CcSEcCtD
Repaglinide—Skin disorder—Methotrexate—multiple sclerosis	0.00021	0.00128	CcSEcCtD
Repaglinide—Vomiting—Triamcinolone—multiple sclerosis	0.000208	0.00127	CcSEcCtD
Repaglinide—Vomiting—Methylprednisolone—multiple sclerosis	0.000208	0.00127	CcSEcCtD
Repaglinide—Rash—Triamcinolone—multiple sclerosis	0.000206	0.00126	CcSEcCtD
Repaglinide—Dermatitis—Triamcinolone—multiple sclerosis	0.000206	0.00126	CcSEcCtD
Repaglinide—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	0.000206	0.00464	CbGpPWpGaD
Repaglinide—Rash—Methylprednisolone—multiple sclerosis	0.000206	0.00126	CcSEcCtD
Repaglinide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000206	0.00126	CcSEcCtD
Repaglinide—Urticaria—Prednisone—multiple sclerosis	0.000205	0.00126	CcSEcCtD
Repaglinide—Headache—Triamcinolone—multiple sclerosis	0.000205	0.00125	CcSEcCtD
Repaglinide—Headache—Methylprednisolone—multiple sclerosis	0.000205	0.00125	CcSEcCtD
Repaglinide—Abdominal pain—Prednisone—multiple sclerosis	0.000204	0.00125	CcSEcCtD
Repaglinide—Diarrhoea—Betamethasone—multiple sclerosis	0.000203	0.00124	CcSEcCtD
Repaglinide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000203	0.00124	CcSEcCtD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000199	0.00449	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000198	0.00445	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000198	0.00445	CbGpPWpGaD
Repaglinide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000197	0.0012	CcSEcCtD
Repaglinide—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000196	0.0044	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000196	0.0044	CbGpPWpGaD
Repaglinide—Nausea—Triamcinolone—multiple sclerosis	0.000194	0.00119	CcSEcCtD
Repaglinide—Paraesthesia—Methotrexate—multiple sclerosis	0.000194	0.00119	CcSEcCtD
Repaglinide—Nausea—Methylprednisolone—multiple sclerosis	0.000194	0.00119	CcSEcCtD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	0.000193	0.00435	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000193	0.00434	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000193	0.00434	CbGpPWpGaD
Repaglinide—Hypersensitivity—Prednisone—multiple sclerosis	0.00019	0.00117	CcSEcCtD
Repaglinide—Dyspepsia—Methotrexate—multiple sclerosis	0.00019	0.00116	CcSEcCtD
Repaglinide—Vomiting—Betamethasone—multiple sclerosis	0.000189	0.00116	CcSEcCtD
Repaglinide—Vomiting—Dexamethasone—multiple sclerosis	0.000189	0.00116	CcSEcCtD
Repaglinide—Rash—Betamethasone—multiple sclerosis	0.000187	0.00115	CcSEcCtD
Repaglinide—Rash—Dexamethasone—multiple sclerosis	0.000187	0.00115	CcSEcCtD
Repaglinide—Dermatitis—Betamethasone—multiple sclerosis	0.000187	0.00114	CcSEcCtD
Repaglinide—Dermatitis—Dexamethasone—multiple sclerosis	0.000187	0.00114	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000187	0.00114	CcSEcCtD
Repaglinide—Headache—Dexamethasone—multiple sclerosis	0.000186	0.00114	CcSEcCtD
Repaglinide—Headache—Betamethasone—multiple sclerosis	0.000186	0.00114	CcSEcCtD
Repaglinide—KCNJ11—brain—multiple sclerosis	0.000186	0.0357	CbGeAlD
Repaglinide—Pruritus—Prednisone—multiple sclerosis	0.000183	0.00112	CcSEcCtD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00018	0.00404	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—BCHE—multiple sclerosis	0.000178	0.00402	CbGpPWpGaD
Repaglinide—Diarrhoea—Prednisone—multiple sclerosis	0.000177	0.00108	CcSEcCtD
Repaglinide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000177	0.00108	CcSEcCtD
Repaglinide—Nausea—Dexamethasone—multiple sclerosis	0.000176	0.00108	CcSEcCtD
Repaglinide—Nausea—Betamethasone—multiple sclerosis	0.000176	0.00108	CcSEcCtD
Repaglinide—KCNJ11—Neuronal System—BCHE—multiple sclerosis	0.000173	0.00389	CbGpPWpGaD
Repaglinide—Urticaria—Methotrexate—multiple sclerosis	0.000172	0.00105	CcSEcCtD
Repaglinide—ABCC8—brain—multiple sclerosis	0.000171	0.0329	CbGeAlD
Repaglinide—Abdominal pain—Methotrexate—multiple sclerosis	0.000171	0.00105	CcSEcCtD
Repaglinide—PPARG—nervous system—multiple sclerosis	0.000171	0.0329	CbGeAlD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000166	0.00374	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000166	0.00374	CbGpPWpGaD
Repaglinide—Vomiting—Prednisone—multiple sclerosis	0.000164	0.00101	CcSEcCtD
Repaglinide—PPARG—central nervous system—multiple sclerosis	0.000164	0.0316	CbGeAlD
Repaglinide—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.000164	0.0037	CbGpPWpGaD
Repaglinide—Rash—Prednisone—multiple sclerosis	0.000163	0.000998	CcSEcCtD
Repaglinide—Dermatitis—Prednisone—multiple sclerosis	0.000163	0.000997	CcSEcCtD
Repaglinide—Headache—Prednisone—multiple sclerosis	0.000162	0.000991	CcSEcCtD
Repaglinide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	0.00016	0.00361	CbGpPWpGaD
Repaglinide—Hypersensitivity—Methotrexate—multiple sclerosis	0.000159	0.000974	CcSEcCtD
Repaglinide—PPARG—Adipogenesis—FAS—multiple sclerosis	0.000154	0.00347	CbGpPWpGaD
Repaglinide—Nausea—Prednisone—multiple sclerosis	0.000154	0.00094	CcSEcCtD
Repaglinide—Pruritus—Methotrexate—multiple sclerosis	0.000153	0.000936	CcSEcCtD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00015	0.00339	CbGpPWpGaD
Repaglinide—Diarrhoea—Methotrexate—multiple sclerosis	0.000148	0.000905	CcSEcCtD
Repaglinide—PPARG—Gene Expression—ZNF746—multiple sclerosis	0.000148	0.00332	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SRM—multiple sclerosis	0.000146	0.0033	CbGpPWpGaD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—MYC—multiple sclerosis	0.000146	0.0033	CbGpPWpGaD
Repaglinide—PPARG—Wnt Signaling Pathway Netpath—MAPK1—multiple sclerosis	0.000143	0.00322	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SRM—multiple sclerosis	0.000142	0.0032	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000142	0.0032	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	0.000141	0.00317	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000139	0.00314	CbGpPWpGaD
Repaglinide—Vomiting—Methotrexate—multiple sclerosis	0.000137	0.000841	CcSEcCtD
Repaglinide—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	0.000137	0.00308	CbGpPWpGaD
Repaglinide—Rash—Methotrexate—multiple sclerosis	0.000136	0.000834	CcSEcCtD
Repaglinide—Dermatitis—Methotrexate—multiple sclerosis	0.000136	0.000833	CcSEcCtD
Repaglinide—Headache—Methotrexate—multiple sclerosis	0.000135	0.000829	CcSEcCtD
Repaglinide—PPARG—Gene Expression—PTBP1—multiple sclerosis	0.000135	0.00304	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.000135	0.00303	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000134	0.00301	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000131	0.00294	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000131	0.00294	CbGpPWpGaD
Repaglinide—PPARG—brain—multiple sclerosis	0.00013	0.0251	CbGeAlD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.00013	0.00292	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL4—multiple sclerosis	0.00013	0.00292	CbGpPWpGaD
Repaglinide—Nausea—Methotrexate—multiple sclerosis	0.000128	0.000786	CcSEcCtD
Repaglinide—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.000126	0.00285	CbGpPWpGaD
Repaglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000126	0.00283	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000125	0.00283	CbGpPWpGaD
Repaglinide—PPARG—Signaling events mediated by HDAC Class I—STAT3—multiple sclerosis	0.000124	0.0028	CbGpPWpGaD
Repaglinide—ALB—brain—multiple sclerosis	0.000122	0.0236	CbGeAlD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000114	0.00257	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.000113	0.00255	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—FAS—multiple sclerosis	0.000109	0.00245	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SELPLG—multiple sclerosis	0.000108	0.00244	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MERTK—multiple sclerosis	0.000108	0.00244	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CD58—multiple sclerosis	0.000108	0.00244	CbGpPWpGaD
Repaglinide—PPARG—Signaling events mediated by HDAC Class I—TNF—multiple sclerosis	0.000107	0.00242	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—PRNP—multiple sclerosis	0.000107	0.0024	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.000107	0.0024	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000105	0.00236	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000105	0.00236	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SRM—multiple sclerosis	0.000105	0.00236	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000104	0.00233	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000104	0.00233	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP27B1—multiple sclerosis	0.000103	0.00232	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CYP24A1—multiple sclerosis	0.000103	0.00232	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—ICAM1—multiple sclerosis	0.000103	0.00232	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—U2AF2—multiple sclerosis	0.000102	0.0023	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—HNRNPA1—multiple sclerosis	0.000102	0.0023	CbGpPWpGaD
Repaglinide—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000102	0.0023	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000101	0.00228	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP27B1—multiple sclerosis	0.0001	0.00225	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CYP24A1—multiple sclerosis	0.0001	0.00225	CbGpPWpGaD
Repaglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	9.96e-05	0.00224	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	9.62e-05	0.00217	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GPC5—multiple sclerosis	9.43e-05	0.00212	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—PGR—multiple sclerosis	9.24e-05	0.00208	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—CCL2—multiple sclerosis	9.21e-05	0.00207	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GPC5—multiple sclerosis	9.15e-05	0.00206	CbGpPWpGaD
Repaglinide—CYP2C8—brain—multiple sclerosis	8.6e-05	0.0166	CbGeAlD
Repaglinide—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	8.59e-05	0.00193	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—PTPRC—multiple sclerosis	8.3e-05	0.00187	CbGpPWpGaD
Repaglinide—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.28e-05	0.00187	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SRM—multiple sclerosis	8.26e-05	0.00186	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	8.18e-05	0.00184	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ZFP36L1—multiple sclerosis	8.08e-05	0.00182	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.01e-05	0.0018	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	7.96e-05	0.00179	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IFNG—multiple sclerosis	7.83e-05	0.00176	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—RRM1—multiple sclerosis	7.82e-05	0.00176	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.64e-05	0.00172	CbGpPWpGaD
Repaglinide—CYP3A4—nervous system—multiple sclerosis	7.62e-05	0.0147	CbGeAlD
Repaglinide—KCNJ11—Metabolism—RRM1—multiple sclerosis	7.58e-05	0.00171	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—STAT3—multiple sclerosis	7.57e-05	0.0017	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.51e-05	0.00169	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.51e-05	0.00169	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.47e-05	0.00168	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.47e-05	0.00168	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP24A1—multiple sclerosis	7.39e-05	0.00166	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP27B1—multiple sclerosis	7.39e-05	0.00166	CbGpPWpGaD
Repaglinide—CYP3A4—central nervous system—multiple sclerosis	7.34e-05	0.0141	CbGeAlD
Repaglinide—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	7.32e-05	0.00165	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.22e-05	0.00163	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.08e-05	0.00159	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TGFB1—multiple sclerosis	7.01e-05	0.00158	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL1B—multiple sclerosis	6.98e-05	0.00157	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL2—multiple sclerosis	6.96e-05	0.00157	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GPC5—multiple sclerosis	6.76e-05	0.00152	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PLEK—multiple sclerosis	6.69e-05	0.00151	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—TNF—multiple sclerosis	6.55e-05	0.00148	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—VDR—multiple sclerosis	6.46e-05	0.00145	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PABPC1—multiple sclerosis	6.27e-05	0.00141	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	6.23e-05	0.0014	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	6.22e-05	0.0014	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	5.82e-05	0.00131	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	5.82e-05	0.00131	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.79e-05	0.0013	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.69e-05	0.00128	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—RPL5—multiple sclerosis	5.65e-05	0.00127	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—RRM1—multiple sclerosis	5.6e-05	0.00126	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	5.55e-05	0.00125	CbGpPWpGaD
Repaglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.48e-05	0.00124	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GPC5—multiple sclerosis	5.32e-05	0.0012	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—IL6—multiple sclerosis	5.29e-05	0.00119	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—MAPK1—multiple sclerosis	5.21e-05	0.00117	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TNF—multiple sclerosis	5.07e-05	0.00114	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—MAPK1—multiple sclerosis	5.05e-05	0.00114	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	5.03e-05	0.00113	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.02e-05	0.00113	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SRM—multiple sclerosis	4.75e-05	0.00107	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SRM—multiple sclerosis	4.72e-05	0.00106	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SELE—multiple sclerosis	4.71e-05	0.00106	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—TGFB1—multiple sclerosis	4.65e-05	0.00105	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.58e-05	0.00103	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.52e-05	0.00102	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	4.51e-05	0.00102	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—BCHE—multiple sclerosis	4.49e-05	0.00101	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PGR—multiple sclerosis	4.45e-05	0.001	CbGpPWpGaD
Repaglinide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.45e-05	0.001	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	4.43e-05	0.000999	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—RRM1—multiple sclerosis	4.41e-05	0.000994	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—POMC—multiple sclerosis	4.4e-05	0.000991	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—BCHE—multiple sclerosis	4.35e-05	0.000981	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.35e-05	0.000979	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—IL6—multiple sclerosis	4.09e-05	0.000921	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.04e-05	0.000911	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	4.03e-05	0.000907	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.73e-05	0.000841	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—IL6—multiple sclerosis	3.73e-05	0.00084	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TYK2—multiple sclerosis	3.71e-05	0.000837	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.42e-05	0.000771	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—ITGA4—multiple sclerosis	3.41e-05	0.000767	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.4e-05	0.000767	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IFNB1—multiple sclerosis	3.38e-05	0.000762	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.34e-05	0.000753	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.34e-05	0.000753	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP27B1—multiple sclerosis	3.33e-05	0.000749	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP24A1—multiple sclerosis	3.33e-05	0.000749	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.27e-05	0.000736	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.25e-05	0.000732	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	3.25e-05	0.000732	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—BCHE—multiple sclerosis	3.22e-05	0.000725	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—VDR—multiple sclerosis	3.11e-05	0.0007	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GPC5—multiple sclerosis	3.06e-05	0.000689	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GPC5—multiple sclerosis	3.04e-05	0.000685	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.94e-05	0.000662	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MMP9—multiple sclerosis	2.93e-05	0.000659	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—APOE—multiple sclerosis	2.7e-05	0.000608	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.68e-05	0.000604	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	2.65e-05	0.000596	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—APOE—multiple sclerosis	2.62e-05	0.00059	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—STAT3—multiple sclerosis	2.6e-05	0.000586	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—MYC—multiple sclerosis	2.57e-05	0.000578	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.55e-05	0.000574	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SRM—multiple sclerosis	2.55e-05	0.000574	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.53e-05	0.000571	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—BCHE—multiple sclerosis	2.53e-05	0.000571	CbGpPWpGaD
Repaglinide—ALB—Metabolism—RRM1—multiple sclerosis	2.52e-05	0.000568	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TGFB1—multiple sclerosis	2.41e-05	0.000543	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK1—multiple sclerosis	2.36e-05	0.000532	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.36e-05	0.000532	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IL2RA—multiple sclerosis	2.33e-05	0.000524	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—POMC—multiple sclerosis	2.32e-05	0.000523	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TNF—multiple sclerosis	2.25e-05	0.000507	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—POMC—multiple sclerosis	2.25e-05	0.000507	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ALB—multiple sclerosis	2.12e-05	0.000476	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	2.06e-05	0.000465	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ALB—multiple sclerosis	2.05e-05	0.000462	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	2.02e-05	0.000456	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.97e-05	0.000443	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.96e-05	0.00044	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APOE—multiple sclerosis	1.94e-05	0.000436	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6—multiple sclerosis	1.82e-05	0.000409	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.8e-05	0.000404	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.8e-05	0.000404	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.69e-05	0.000381	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.68e-05	0.000378	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—POMC—multiple sclerosis	1.66e-05	0.000375	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.64e-05	0.00037	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.54e-05	0.000347	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOE—multiple sclerosis	1.52e-05	0.000343	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALB—multiple sclerosis	1.52e-05	0.000341	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.46e-05	0.000328	CbGpPWpGaD
Repaglinide—ALB—Metabolism—BCHE—multiple sclerosis	1.45e-05	0.000326	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IL2—multiple sclerosis	1.36e-05	0.000307	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.36e-05	0.000306	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—POMC—multiple sclerosis	1.31e-05	0.000295	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MYC—multiple sclerosis	1.24e-05	0.000278	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALB—multiple sclerosis	1.19e-05	0.000269	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TGFB1—multiple sclerosis	1.06e-05	0.00024	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK1—multiple sclerosis	1.04e-05	0.000235	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOE—multiple sclerosis	8.76e-06	0.000197	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOE—multiple sclerosis	8.71e-06	0.000196	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.81e-06	0.000176	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—POMC—multiple sclerosis	7.52e-06	0.000169	CbGpPWpGaD
Repaglinide—ALB—Metabolism—POMC—multiple sclerosis	7.48e-06	0.000168	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALB—multiple sclerosis	6.86e-06	0.000154	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOE—multiple sclerosis	4.7e-06	0.000106	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—POMC—multiple sclerosis	4.04e-06	9.1e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALB—multiple sclerosis	3.68e-06	8.29e-05	CbGpPWpGaD
